Manganese-DPDP as a hepatobiliary contrast agent in the magnetic resonance imaging of liver tumors. Results of clinical phase II trials in Germany including 141 patients.
Rummeny
E
E
Department of Radiology, University of Muenster, Germany.
Ehrenheim
C
C
Gehl
H B
HB
Hamm
B
B
Laniado
M
M
Lodemann
K P
KP
Schmiedel
E
E
Steudel
A
A
Vogl
T G
TG
D001659:Biliary Tract / Q000473:pathology*; D003287:Contrast Media / Q000009:adverse effects; D004341:Drug Evaluation; D004361:Drug Tolerance; D004492:Edetic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D005858:Germany; D006801:Humans; D008099:Liver / Q000473:pathology*; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000556:secondary; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008345:Manganese / Q000009:adverse effects; D011732:Pyridoxal Phosphate / Q000009:adverse effects / Q000031:analogs & derivatives*
D003287:Contrast Media; D008345:Manganese; D011732:Pyridoxal Phosphate; D004492:Edetic Acid; C060076:N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid